Implementation in Community
|
|
- Darleen Horn
- 8 years ago
- Views:
Transcription
1 Medication-Assisted i t d Treatment t Implementation in Community Correctional Environments (MATICCE) CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA.
2 What is Medication-Assisted Treatment (MAT)? MAT is the use of medications in combination with counseling and behavioral therapies to provide a whole-patient t approach to the treatment t t of substance use disorders. Medications address withdrawal, craving & reinforcing euphoria. Research shows that when treating substance use disorders, a combination of medication and behavioral therapies is most successful. CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 2
3 Why Focus on MAT in Community Corrections (Probation/Parole)? MAT Planning Survey RCs surveyed all potential CJ partner sites (N=50) Demonstrated several barriers to using MAT in CJ settings: Perceptions that MAT available in the community Security/Liability issues Cost/Regulatory issues Lack of knowledge about effectiveness ect e ess of MAT Philosophical opposition to MAT Parole/Probation sites: lowest current use of MAT most potential for initiating/expanding MAT CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 3
4 Specific Barriers to Implementing MAT in Community Corrections Community Corrections (CC) defers responsibility to existing community treatment providers but weak referral relationships exist Lack of knowledge about effectiveness Philosophical opposition to MAT Strategy for overcoming barriers: Address staff knowledge/perceptions and work to improve working relationship between CC and existing community treatment agencies (interorganizational linkages) CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 4
5 Specific Aims Aim 1: Improve service coordination between Community Corrections agencies and local MAT-providing tx agencies. Aim 2: Improve CC agents knowledge, perceptions, and information about referral resources and intent to refer appropriate clients to community-based MAT. Aim 3: Increase the number of CC clients linked with MAT. Aims will be accomplished by testing: a staff-level Knowledge, Perceptions, and Information (KPI) training intervention; and an interorganizational linkage intervention. CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 5
6 bh3 Two-Part Implementation Strategy: Part 1 Knowledge, perception & information (KPI) Training of CC staff and selected staff from assessment & treatment agencies to address: lack of knowledge about effectiveness philosophical preference for abstinence-based treatment Information and understanding about local MAT resources Delivered by regional Addiction Technology Transfer Centers (ATTCs) based on NIDA/CSAT Blending Initiative materials CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 6
7 Slide 6 bh3 changed second check mark to specifically name the Blending Initiative bhall, 4/8/2010
8 KPI Outline Address Community Corrections (CC) perspectives on MAT through open discussion Basics of brain functioning in relation to MAT with features of special interest to those in CJ professions Medications used to treat alcoholism, evidence about effectiveness and side effects Medications used to treat opiates, evidence about effectiveness and side effects Examples of typical CC clients who could benefit from MAT Reasons that those under CC supervision with addiction histories might be good candidates for MAT Rapid re-addiction after release, opiate overdose, alcohol and violent crime CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 7
9 KPI Outline, cont d Advantages that MAT might offer the criminal justice system evidence-based practice reduced numbers of addicts going through repeated arrest-incarceration-release ti cycles would likely l result in decreased in crime associated with addiction and in lower public safety costs formal linkages with medication-assisted i t d treatment t t agencies could simplify supervision and lower parole/probation supervision costs How to decide if someone is a good candidate for referral to MAT Types of agencies where MAT is typically offered CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 8
10 Two-Part Implementation Strategy Part 2: Interorganizational linkage intervention (OLI) Incorporates 3 aspects of CMHS ACCESS intervention considered most effective Pharmacotherapy Exchange Councils (PEC) Representatives from relevant local agencies Co-chaired by directors of CC and local MAT providers (or designees) Charged to address linkage to MAT-enabled providers CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 9
11 Two-Part Implementation Strategy Organizational Linkage Intervention (OLI) Strategic Planning by PEC Facilitated by local research team Address factors influencing linkages to MAT Acknowledge complexity of system Connections Coordinator Position Coordinate PEC activities; liaison, foster consensus among agencies Key person, trusted by all participants CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 10
12 PEC Membership The PEC includes... Co-Chairs with the authority to change policy, or at least those who have direct communication to those with such authority Dedicated Connections Coordinator who works closely with members of the PEC in carrying out the OLI Supervisory and line staff familiar with issues and operations Researcher (usually affiliated with the research center) who will be called upon to provide technical, administrative, and logistical support to the PEC CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA
13 Overview of Phases for the Organizational Linkage Intervention(OLI) ti Phase Pre-PhasePhase 1. Needs Assessment Primary Outcome(s) Local PEC Team is formed and the MATICCE project is introduced PEC completes a Needs Assessment that identifies the relative strengths & weaknesses in the inter- organizational practices associated with MAT Duration (in weeks) Strategic Planning PEC develops and adopts a Strategic Plan that 8-12 identifies goals and objectives for improvements to increase the use of MAT 3. Implementation ti PEC works in a collaborative manner to implement the objectives and attain the goals identified in their Strategic Plan 4. Follow-Up PEC assesses the relative sustainability of both the process improvement targets achieved and the PEC method for facilitating process improvements
14 Jun -Nov 2010 (6 mo) Oct Dec 2010 (3 mo) Jan Feb 11 (2 mo) Study Design Pre-Intervention Pilot Phase Test chart data collection procedures Baseline Data Collection (all sites) Knowledge, Attitude, Information (KPI) Intervention (all sites) RANDOMIZATION PHASE 1 PHASE 2 Group 1 Linkage Intervention Feb 11-Dec 12 (12 mo) PEC Strategic Planning Connection Coordinator Group 2 No Linkage Intervention (KPI only ) PHASE 3 Jan Feb 12 (2 mo) End-of-Phase 3 Data Collection (all sites) Jun-Jul 12 (2 mo) After Jul 12 6-Month Follow-up Data Collection (all sites) If linkage intervention is effective, offer materials and training to Group 2 Analysis Phase
15 Nineteen Site Study Intervention based in community corrections (i.e., probation/parole) Each CC office would identify at least one local addiction pharmacotherapy-providing treatment agency to which client referrals can be made opioid treatment programs providing methadone or buprenorphine outpatient programs providing bup or naltrexone for opioid dep. or naltrexone, acamprosate or disulfiram for alcohol dependence Each RC would contribute at least 2 CJ sites to the protocol, preferably in distinct geographic catchment areas Catchment area distinction helps avoid contamination (especially of tx providers) in the delayed implementation group CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 14
16
17 What: Sources of Data SURVEY QUALITATIVE AGENCY RECORDS INTERVIEWS -interorganizational relations (IOR) between criminal justice and treatment e agencies es participating in the study -knowledge perceptions and information (KPI) about MAT. Compliment and supplement the information o from the surveys. -Probation/parole and/or Tx agency records (electronic data, presentencing e evaluations, contact records, formal assessments, urinalysis results, etc.). -Abstract 200 client files with evidence of opioid or alcohol use. Who: Representative sample of -probation/parole personnel (director, supervisors, and POs) -treatment personnel (e.g., director, clinical supervisor, counselors, medical director). -All correctional staff with specialized substance abuse caseload Selected subsample of 4 survey respondents, 4 PEC members, and Connections Coordinator. -Researchers and trained assistants, with cooperation of participating agencies. -All procedures approved by RC Institutional Review Boards to ensure compliance with Human Subjects requirements.
18 17
19 Hypothesis 1 CC units in the KPI+Linkage intervention will have greater relative to baseline in interorganizational tx svc coordination than those with KPI alone. Relates to Aim 1 (improve service coordination) Compares Groups 1 (KPI+Linkage) & 2 (KPI) at end of Phase 3 Outcomes Baseline Survey of Organizational Characteristics (BSOC) ACCESS measures (e.g., Morrissey et al., 2002) Interorg Relations Survey adapted from Van de Ven, 1980 Data sources Semi-structured interviews & CC staff surveys at baseline & end of Phase 3 CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 18
20 Hypothesis 2 After the KPI training, CC officers will have knowledge/perceptions re: evidence for MAT, use in treatment, and where to refer clients Relates to Aim 2 (staff knowledge & intent) Compares staff baseline-post KPI training in both groups Outcomes Opinions i about MAT Survey adapted d from Fitzgerald & McCarty, 2009; Springer & Bruce, 2008; Gjersing et al Data sources CC staff surveys at baseline and after KPI training CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 19
21 Hypothesis 3 Staff in KPI + Linkage group will have greater in intent to refer clients to MAT vs KPI alone Relates to Aim 2 (staff knowledge & intent to refer) Compares Group 1 vs. Group 2 staff baseline-post Phase 3. Outcomes Intent to refer on Likert-type scales (Varra et al., 2008) Data sources CC staff surveys at baseline & end of Phase 3 CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 20
22 Hypothesis 4 d interorganizational tx service coordination and staff knowledge / perceptions / referral practices will be sustained 6 months after intervention period. Relates to Aim 1 (service coordination) Compares Group 1 vs. Group 2 across all data collection periods Outcomes Interorganizational coordination measures per H1 KPI and intent to refer scales per H2, H3 Data sources CC staff surveys, semi-structured t interviews i at baseline, end of Phase 3 & 6-months later CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 21
23 Hypothesis 5 CC units in KPI+Linkage group will have a greater over baseline in % opioid/alcohol-using clients referred to MAT assessment than KPI only group. Relates to Aim 3 (increase client linkages) Compares Group 1 vs. Group 2 across all data collection periods Outcomes % opioid-/alcohol- using clients referred for assessment for MAT Data sources CC records for 6 mos prior to baseline, last 6 months of Phase 3, and 6 months after Phase 3* Monthly CC officer survey for month prior to baseline, last 6 months of Phase 3, and 6 months after Phase 3, reporting: # opioid/alcohol-using clients # clients referred for MAT assessment CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 22
24 Hypothesis 6 CC units in KPI + Linkage group will have a greater over baseline in clients assessed by a tx provider for MAT and who initiate MAT, vs. KPI only group Relates to Aim 3 (increase client linkages) Compares Group 1 vs. Group 2 staff baseline-phase 3 Outcomes # completed CJ referrals for assessment, MAT initiates, persondays on MAT Data sources Records abstract or report from substance abuse assessment provider and main MAT program for 6 mos prior to baseline & last 6 mos of Phase 3* CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 23
25 Hypothesis 7 CC units in KPI+Linkage group will have a larger relative to baseline in opioid/alcohol-using clients rearrested, re-incarcerated, & testing positive for substance use relative to KPI only group. Relates to Aim 3 (increase client linkages) Compares Group 1 vs. Group 2 staff baseline-phase 3. Outcomes: Of potentially MAT appropriate p CC clients i % arrested, reincarcerated, testing positive for drugs Data sources Records abstract or report from CC, CJ and drug-testing program for 6 mos prior to baseline, last 6 mos of Phase 3, & 6 mos after Phase 3. CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 24
26 Challenges and Limitations If site cannot accept randomization assignment MATICCE SMS will recommend action, incl replacement if necessary. Protocol deviations Change in staff or level of cooperation Retraining Analyses by intent to treat Client Information Waiver IRB variability Unclear whether treatment programs will honor waiver Can still examine primary outcomes from CJ and survey data Extent, validity of record documentation reasonable from pilot Possible detection bias based on Group (hard to blind RAs) Self-report data Limited information on psychometrics of these reports Social desirability / Hawthorne effects CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 25
27
28 Summary Addressing i staff knowledge/perceptions and interorganizational linkages could increase CC clients access to MAT MATICCE -- multi-site, cluster randomized study Compares KPI training alone to KPI training plus active linkage intervention ti Interorganizational Pharmacotherapy Exchange Council (PEC) Facilitated strategic planning Connections coordinator position Complex project that will attempt to address issues in implementation science (interorg. relationships; sustainability) HSR (structural influences on access, referral, and utilization) practical concerns of CJ agencies (facilitating interagency referrals; reducing relapse & arrest) Reproducible manual, training materials CJ-DATS is funded by NIDA in collaboration with SAMHSA and BJA. 27
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationTreatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationThe Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationRevenue Streams Associated with the Implementation of Medication-Assisted Treatment for Opioid Dependence
Revenue Streams Associated with the Implementation of Medication-Assisted Treatment for Opioid Dependence Hannah K. Knudsen, Ph.D. Amanda J. Abraham, Ph.D. Lauren O Brien Paul M. Roman Acknowledgements
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationBehavioral Health Provider Implementation of Whole Health Integrative Treatment Services
Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services Maryland Integrative Learning Community Lynn H Albizo, Director of Public Affairs Maryland Addictions Directors
More informationThis module will assist participants to:
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module V: Coordinated Care Effective Coordination of Care Effective coordination combines the strengths of various systems
More informationCollege on Problems of Drug Dependence San Diego, June 19, 2013
Michael Prendergast, University of California Los Angeles Michael Shafer, Arizona State University Umme Warda, University of California Los Angeles Wayne Welsh, Temple University Gerald Melnick, National
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
More informationEvidence-Based Corrections & Treatment
Evidence-Based Corrections & Treatment Faye S. Taxman, Ph.D. ftaman@gmu.edu How are Correctional Agencies Doing in Adopting Evidence-Based Substance Abuse Treatment Programs and Services? Offenders are
More informationImplementation Science & the Criminal Justice Drug Abuse Treatment Studies
Implementation Science & the Criminal Justice Drug Abuse Treatment Studies Second Generation Academic and Health Policy Conference on Correctional Health Atlanta, GA; March 22, 2012 1 CJ-DATS Research
More informationSubject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 6 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
More informationUse of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
More informationRecovery Outcomes for Opiate Users. FRN Research Report November 2013
Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationSubject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 8 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
More informationThe Begun Center is currently serving as the evaluator for five drug courts in Ohio receiving SAMHSA grant funding. http://begun.case.
The Begun Center for Violence and Prevention Research & Education at Case Western Reserve University has been awarded the contract to evaluate the effectiveness of Ohio s Addiction Treatment Pilot Program
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationWelcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug
Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug abuse treatment principles for individuals involved in the
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationNIDA/SAMHSA Blending Initiative Overview: A Focus on Medication Assisted Treatment
NIDA/SAMHSA Blending Initiative Overview: A Focus on Medication Assisted Treatment Thomas E. Freese, Ph.D., & Beth Rutkowski, M.P.H. AHSR, October 2011 What s the Issue? A significant delay exists between
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationSubstance Abuse Service Delivery Model
Substance Abuse Service Delivery Model SERVICE CATEGORY: SUBSTANCE ABUSE SERVICES Goal: Provide access to quality Substance Abuse services that follow federal, state, and local standards in order to facilitate
More informationLimiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?
Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt? Medicaid Evidence-Based Decisions Project June 25, 2014 Supported by National Institute
More informationOpioid Treatment Programs at the Baltimore City Detention Center
Opioid Treatment Programs at the Baltimore City Detention Center Greg Warren, MA, MBA Director of Substance Abuse Services Maryland Department of Public Safety and Correctional Services OTP Interventions
More informationEvidence Based Practice in the Treatment of Addiction Treatment of Addiction. Steve Hanson
Evidence Based Practice in the Treatment of Addiction Treatment of Addiction Steve Hanson History of Addiction Treatment Incarceration Medical Techniques Asylums What We Learned These didn t work Needed
More informationVarious therapies are used in the
National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Overview of Opioid Treatment Programs within the United States: 2008 In Brief In 2008, a total of 1,132 (8 of all
More informationDeveloping Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse
Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine
More informationRequest for Applications
Palm Beach County Department of Public Safety Justice Services Division Palm Beach County Drug Court Programs Substance Abuse Treatment Request for Applications Release Date: June 30, 2015 Due Date: July
More informationAttitudes toward evidence-based pharmacological treatments among community-based addiction treatment programs targeting vulnerable patient groups
Attitudes toward evidence-based pharmacological treatments among community-based addiction treatment programs targeting vulnerable patient groups Center for Addictions Research and Services, Boston University
More informationA Drug Policy for the 21st Century. Office of National Drug Control Policy
A Drug Policy for the 21st Century October 18, 2014 International Nurses Society on Addictions Health Care Reform & Its Impact on Addictions Nursing: Navigating Change through the Rapids David K. Mineta,
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationState Perspectives on Buprenorphine and Office-Based Treatment
State Perspectives on Buprenorphine and Office-Based Treatment The National Association of State Alcohol and Drug Abuse Directors (NASADAD) For the Center for Substance Abuse Treatment (CSAT) With support
More informationTreatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
More informationAlcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD
Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,
More informationPutting Addiction Treatment Medications to Use: Lessons Learned
Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia
More informationSimplifying MAT. Medication-Assisted Treatment in Arizona
Simplifying MAT Medication-Assisted Treatment in Arizona MAT Perceptions about Medication-Assisted Treatment Addiction need not be a life sentence. Individuals in need of treatment for substance use disorders
More informationH-SOAP STUDY. Hospital-based Services for Opioid- and Alcohol-addicted Patients
H-SOAP STUDY Hospital-based Services for Opioid- and Alcohol-addicted Patients Meldon Kahan, Anita Srivastava, Kate Hardy, Sarah Clarke Canadian Society of Addiction Medicine 2014 October 17, 2014 1 Few
More informationDrug Medi-Cal. What this is about...
Drug Medi-Cal Organized Delivery System Waiver Challenges and Opportunities What this is about... Expanding availability of SUD treatment for low income residents of California. Creating a continuum of
More informationState Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff
State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff Funding Source: Grant No. 053773 Robert Wood Johnson Foundation Substance Abuse Policy Research
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationMST and Drug Court. Family Services Research Center Medical University of South Carolina Funded by NIDA and NIAAA
MST and Drug Court Family Services Research Center Medical University of South Carolina Funded by NIDA and NIAAA Project Staff Scott Henggeler Jeff Randall Phillippe Cunningham Colleen Halliday-Boykins
More informationDepot Naltrexone Appears Safe and Effective for Heroin Addiction
of 2 http://www.drugabuse.gov/nida_notes/nnvol21n3/depot.html 10/20/2011 11:23 AM NIDA NEWS NIDA Home > Publications > NIDA Notes > Vol. 21, No. 3 > Research Findings Depot Naltrexone Appears Safe and
More informationCounselor Attitudes Toward Pharmacotherapies for Alcohol Dependence
Counselor Attitudes Toward Pharmacotherapies for Alcohol Dependence Lori J. Ducharme, Ph.D. Hannah K. Knudsen, Ph.D. Paul M. Roman, Ph.D. University of Georgia 1 Counselors, Pharmacotherapies, and Alcohol
More informationAdvocating for Your Recovery: What to Do When Ordered Off Addiction Medication
Advocating for Your Recovery: What to Do When Ordered Off Addiction Medication My Probation Officer instructed me to taper off Suboxone. Can he do that? The judge won t give me custody of my kids unless
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationPatients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
More informationObjectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
More informationSubstance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008
Treatment Episode Data Set The TEDS Report July 15, 010 Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 008 In Brief The proportion of all substance abuse treatment admissions
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationHow To Be A Successful Supervisor
Quick Guide For Administrators Based on TIP 52 Clinical Supervision and Professional Development of the Substance Abuse Counselor Contents Why a Quick Guide?...2 What Is a TIP?...3 Benefits and Rationale...4
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationRe-Thinking Addiction Treatment: Have We Been Thinking Correctly?
Re-Thinking Addiction Treatment: Have We Been Thinking Correctly? Scope of Substance Use in the US Alcohol, Illicit & non-prescribed drugs Very Frequent Use In Specialty Treat. ~ 2,300,000 Addiction Dx
More informationBUPRENORPHINE TREATMENT
BUPRENORPHINE TREATMENT Curriculum Infusion Package (CIP) Based on the Work of Dr. Thomas Freese of the Pacific Southwest ATTC Drug Addiction Treatment Act of 2000 (DATA 2000) Developed by Mountain West
More informationFree Additional Resources
Free Additional Resources Substance Abuse and Mental Health Services Administration Treatment Improvement Protocols The Substance Abuse and Mental Health Services Administration (SAMHSA) offers free Treatment
More informationSUBSTANCE ABUSE OUTPATIENT SERVICES
SUBSTANCE ABUSE OUTPATIENT SERVICES A. DEFINITION: Substance Abuse Outpatient is the provision of medical or other treatment and/or counseling to address substance abuse problems (i.e., alcohol and/or
More informationFRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
More informationThe FUNDAMENTALS Of DRUG TREATMENT COURT. Hon. Patrick C. Bowler, Ret.
The FUNDAMENTALS Of DRUG TREATMENT COURT Hon. Patrick C. Bowler, Ret. Drug Treatment Courts A New Way Partner with Treatment Transform Roles Non-adversarial/Team Shared Goal of Recovery Communication Immediate
More informationOpioid Agonist Treatment in Correctional Settings
Opioid Agonist Treatment in Correctional Settings Robert P. Schwartz, M.D. Friends Research Institute Open Society Institute - Baltimore Treating Heroin-Addicted Prisoners Opioid agonist treatment is widely
More informationDRUG ABUSE TREATMENT
GAO United States General Accounting Office Report to the Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, House of Representatives February 2000 DRUG
More information8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview
Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance
More informationCurrent Models of Recovery Support Services: Where We Have Data and Where We Don t
Current Models of Recovery Support Services: Where We Have Data and Where We Don t Richard Rawson, Ph.D. Integrated Substance Abuse Programs University of California, Los Angeles 1. Define recovery Talk
More informationA Multi-Centre Efficacy Trial of Naltrexone Maintenance Therapy in Hong Kong
A Multi-Centre Efficacy Trial of Naltrexone Maintenance Therapy in Hong Kong Executive Summary 1. Study Background 1.1 In May 1999, upon the recommendations of the Action Committee Against Narcotics (ACAN)
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationGreater Baltimore HIV Health Services Planning Council
Greater Baltimore HIV Health Services Planning Council Service Category Standards of Care Substance-abuse Treatment Services Outpatient Originated Revised Ratified October 1997 August 2001 August 2001
More informationA Drug Policy for the 21st Century
A Drug Policy for the 21st Century April 26, 2014 California Association for Alcohol and Drug Educators (CAADE) Conference Integrating Mental Health and Substance Use Disorder Services David K. Mineta,
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationReforming the Response To Substance Use: A Drug Policy for the 21 st Century
Reforming the Response To Substance Use: A Drug Policy for the 21 st Century 2015 NASADAD MEETING Charleston, SC June 2, 2015 David Mineta, Deputy Director Office of Demand Reduction Office of National
More informationHow To Stop A Prison From Getting A Drug And Alcohol Addiction Treatment
STOPPING THE REVOLVING PRISON DOOR: AN ADDICTION TREATMENT TOOLKIT TO PREVENT DRUG USE AND CRIME, PROMOTE SUCCESSFUL REENTRY INTO SOCIETY, AND SAVE LIVES Developed by the Legal Action Center in Collaboration
More informationAdvances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014
Advances in Addiction Science and Treatment Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Treatment Research Research Institute, Institute, 20132012 Presentation 1. What is driving
More informationMental Health & Addiction Forensics Treatment
Mental Health & Addiction Forensics Treatment Sheriffs: Help needed to cope with September 15, 2014 mentally ill INDIANAPOLIS - A sheriff says county jails have become the "insane asylums" for Indiana
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationSUBSTANCE ABUSE OUTPATIENT
SUBSTANCE ABUSE OUTPATIENT Service Category Description Substance abuse services - outpatient is the provision of medical or other treatment and/or counseling to address substance abuse problems (i.e.,
More informationOn-line Continuing Education. Course Material: Exam Questions Packet
BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA 95662-4019 Telephone (916) 987-2007 Facsimile (916) 987-8823 On-line Continuing Education Course Material and Exam Questions Packet Course
More information2011 State Profile California
20 State Profile California National Survey of Substance Abuse Treatment Services (N-SSATS) The National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual survey of facilities providing
More informationAddiction Messenger Part 1: Medication-Assisted Treatment - Setting the Context
Addiction Messenger Part 1: - Setting the Context "When you love someone who suffers from the disease of addiction you await the phone call. There will be a phone call. T he sincere hope is that the call
More informationNEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES
CHAPTER He-W 500 MEDICAL ASSISTANCE PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES He-W 513.01 Purpose. The purpose of this part is to establish the procedures and requirements
More informationHow To Get Counseling In Ohio
Attachment 1 Ohio Administrative Code» 3793:2 Program Standards» Chapter 3793:2-1 Alcohol and Drug Addiction Programs 3793:2-1-08 Treatment services. (A) The purpose of this rule is to define alcohol and
More informationThe Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence
M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationPERFORMANCE MEASURES FOR SUBSTANCE USE DISORDERS: CURRENT KNOWLEDGE AND KEY QUESTIONS
PERFORMANCE MEASURES FOR SUBSTANCE USE DISORDERS: CURRENT KNOWLEDGE AND KEY QUESTIONS Deborah Garnick Constance Horgan Andrea Acevedo, The Heller School for Social Policy and Management, Brandeis University
More informationShort Term Opioid Withdrawal Using Buprenorphine
Short Term Opioid Withdrawal Using Buprenorphine ٢ Table of Contents Introduction to the Training... 5 Background Information: NIDA-SAMHSA Blending Initiative... 5 Focus on Buprenorphine... 5 Blending
More informationMedication is not a part of treatment.
Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained
More informationOpioid Addiction & Corrections
Opioid Addiction & Corrections Medication Assisted Treatment in the Connecticut Department of Correction April 30, 2015--CJPAC Kathleen F. Maurer, MD, MPH, MBA Medical Director and Director of Health and
More informationOpioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015
Q: I have read 40 mg of methadone stops withdrawal, so why don t we start at 30mg and maybe later in the day add 10mg? A: Federal Regulations stipulate that 30mg is the maximum first dose in an Opioid
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationPerformance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
More informationTraining rural practitioners to use buprenorphine: Using The Change Book to facilitate technology transfer
Journal of Substance Abuse Treatment 26 (2004) 203 208 Regular article Training rural practitioners to use buprenorphine: Using The Change Book to facilitate technology transfer Dennis McCarty a, *, Traci
More informationExpanding the Use of. Creating Change on the Ground: Opportunities and Lessons Learned from the Field
Expanding the Use of Medications to Treat Individuals with Substance Use Disorders in Safety-Net Settings Creating Change on the Ground: Opportunities and Lessons Learned from the Field September 2014
More informationSubstance Abuse Treatment Certification Rule Chapter 8 Alcohol and Drug Abuse Subchapter 4
1.0 Authority Substance Abuse Treatment Certification Rule Chapter 8 Alcohol and Drug Abuse Subchapter 4 1.1 This rule is adopted pursuant to 8 V.S.A 4089b and 18 V.S.A 4806. 2.0 Purpose 2.1 This rule
More informationAddiction Technology Transfer Center
Addiction Technology Transfer Center Unifying science, education and services to transform lives. www.nattc.org 1 The Addiction Technology Transfer Center Network Funded by Substance Abuse and Mental Health
More informationThe Need for Medication-Assisted Treatment (MAT)
Presenters Erin Hall MSOT Hon. Kyle B. Haskins Closed Doors or Welcome Mat? Opening the Way for Medication-Assisted Treatment in Family Drug Courts Oklahoma Specialty Court Conference Thursday September
More informationThe Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
More informationCENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES. York, PA. August 18, 2015
CENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES York, PA August 18, 2015 Hello. My name is Jack Carroll, and I m the Executive Director of the Cumberland-Perry Drug and
More information